Incidence of Endometrial Cancer on the Rise Across Racial Groups

This article originally appeared here.
Share this content:
Incidence of Endometrial Cancer on the Rise Across Racial Groups
Incidence of Endometrial Cancer on the Rise Across Racial Groups

WEDNESDAY, Aug. 19, 2015 (HealthDay News) -- The incidence of endometrial cancers is elevated for women across all racial/ethnic groups, while non-Hispanic black women have excess incidence of aggressive cancers and lower survival, according to a study published online Aug. 19 in Cancer Epidemiology, Biomarkers & Prevention.

Michele L. Cote, Ph.D., from Wayne State University in Detroit, and colleagues analyzed endometrial cancer incidence and mortality data from the Surveillance, Epidemiology, and End Results program from 2000 to 2011. They examined age-adjusted incidence and incidence-based mortality rates, as well as annual percent changes (APCs). Racial/ethnic groups were compared by calculating rate ratios.

The researchers observed increasing incidence rates for endometrial cancers across all racial/ethnic groups, with the greatest APC seen for non-Hispanic black and Asian women (APC, 2.5 for both). The incidence rates of aggressive endometrial cancers were significantly higher for non-Hispanic black versus non-Hispanic white women. For all tumor subtypes, incidence rates for Hispanic and Asian women were equal to or lower than non-Hispanic white women. Compared with non-Hispanic white women, the five-year relative survival for non-Hispanic black women was significantly less for nearly every stage and subtype, while Hispanic and Asian women had the same or better survival.

"Endometrial cancer incidence is increasing for all women, particularly the aggressive subtypes," the authors write. "The disparity associated with excess incidence for these aggressive histologic subtypes and poorer survival is limited to non-Hispanic black women."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »